162 related articles for article (PubMed ID: 21243491)
1. Leflunomide use in a cytomegalovirus infection of a patient with dermatomyositis.
Orden AO; Chuluyan JC; Colombini AC; Barbera RF
Rheumatol Int; 2012 Jan; 32(1):273-5. PubMed ID: 21243491
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus-induced interstitial pneumonitis in a patient with dermatomyositis.
Kaşifoğlu T; Korkmaz C; Ozkan R
Clin Rheumatol; 2006 Sep; 25(5):731-3. PubMed ID: 16267608
[TBL] [Abstract][Full Text] [Related]
3. Can leflunomide play a role in cytomegalovirus disease prophylaxis besides its antirheumatic effects?
Lu CH; Tsai JH; Wu MZ; Yu CL; Hsieh SC
Antivir Ther; 2015; 20(1):93-6. PubMed ID: 24831792
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus infection complicating immunosuppressive therapy for dermatomyositis.
Hashimoto A; Okuyama R; Watanabe H; Tagami H; Aiba S
Acta Derm Venereol; 2006; 86(6):535-7. PubMed ID: 17106602
[TBL] [Abstract][Full Text] [Related]
5. Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide.
Ehlert K; Groll AH; Kuehn J; Vormoor J
Klin Padiatr; 2006; 218(3):180-4. PubMed ID: 16688677
[TBL] [Abstract][Full Text] [Related]
6. Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.
Waldman WJ; Knight DA; Lurain NS; Miller DM; Sedmak DD; Williams JW; Chong AS
Transplantation; 1999 Sep; 68(6):814-25. PubMed ID: 10515382
[TBL] [Abstract][Full Text] [Related]
7. Leflunomide for cytomegalovirus: bench to bedside.
Chacko B; John GT
Transpl Infect Dis; 2012 Apr; 14(2):111-20. PubMed ID: 22093814
[TBL] [Abstract][Full Text] [Related]
8. Leflunomide as a rescue treatment in ganciclovir-resistant cytomegalovirus infection in a seronegative renal transplant recipient--a case report.
Ciszek M; Mucha K; Foroncewicz B; Chmura A; Pączek L
Ann Transplant; 2014 Jan; 19():60-3. PubMed ID: 24481271
[TBL] [Abstract][Full Text] [Related]
9. Concurrent antiviral and immunosuppressive activities of leflunomide in vivo.
Chong AS; Zeng H; Knight DA; Shen J; Meister GT; Williams JW; Waldman WJ
Am J Transplant; 2006 Jan; 6(1):69-75. PubMed ID: 16433758
[TBL] [Abstract][Full Text] [Related]
10. [Management of cytomegalovirus infections in patients treated with immunosuppressive drugs for chronic inflammatory diseases].
Tnani N; Massoumi A; Lortholary O; Soussan P; Prinseau J; Baglin A; Hanslik T
Rev Med Interne; 2008 Apr; 29(4):305-10. PubMed ID: 18068874
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus infection in organ transplant recipients.
Hibberd PL; Snydman DR
Infect Dis Clin North Am; 1995 Dec; 9(4):863-77. PubMed ID: 8747770
[TBL] [Abstract][Full Text] [Related]
12. Treatment of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide.
Levi ME; Mandava N; Chan LK; Weinberg A; Olson JL
Transpl Infect Dis; 2006 Mar; 8(1):38-43. PubMed ID: 16623819
[TBL] [Abstract][Full Text] [Related]
13. Leflunomide: a possible alternative for gangciclovir sensitive and resistant cytomegalovirus infections.
Sudarsanam TD; Sahni RD; John GT
Postgrad Med J; 2006 May; 82(967):313-4. PubMed ID: 16679469
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide.
Waldman WJ; Knight DA; Blinder L; Shen J; Lurain NS; Miller DM; Sedmak DD; Williams JW; Chong AS
Intervirology; 1999; 42(5-6):412-8. PubMed ID: 10702725
[TBL] [Abstract][Full Text] [Related]
15. Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature.
Verkaik NJ; Hoek RA; van Bergeijk H; van Hal PT; Schipper ME; Pas SD; Beersma MF; Boucher CA; Jedema I; Falkenburg F; Hoogsteden HC; van den Blink B; Murk JL
Transpl Infect Dis; 2013 Dec; 15(6):E243-9. PubMed ID: 24298985
[TBL] [Abstract][Full Text] [Related]
16. Utility of leflunomide in the treatment of complex cytomegalovirus syndromes.
Avery RK; Mossad SB; Poggio E; Lard M; Budev M; Bolwell B; Waldman WJ; Braun W; Mawhorter SD; Fatica R; Krishnamurthi V; Young JB; Shrestha R; Stephany B; Lurain N; Yen-Lieberman B
Transplantation; 2010 Aug; 90(4):419-26. PubMed ID: 20683281
[TBL] [Abstract][Full Text] [Related]
17. Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection.
Avery RK; Bolwell BJ; Yen-Lieberman B; Lurain N; Waldman WJ; Longworth DL; Taege AJ; Mossad SB; Kohn D; Long JR; Curtis J; Kalaycio M; Pohlman B; Williams JW
Bone Marrow Transplant; 2004 Dec; 34(12):1071-5. PubMed ID: 15489872
[TBL] [Abstract][Full Text] [Related]
18. The use of sirolimus in patients with recurrent cytomegalovirus infection after kidney transplantation: A retrospective case series analysis.
Shendi AM; Hung RKY; Caplin B; Griffiths P; Harber M
Saudi J Kidney Dis Transpl; 2019; 30(3):606-614. PubMed ID: 31249224
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus and ulcerative colitis: Place of antiviral therapy.
Pillet S; Pozzetto B; Roblin X
World J Gastroenterol; 2016 Feb; 22(6):2030-45. PubMed ID: 26877608
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series.
El Chaer F; Mori N; Shah D; Oliver N; Wang E; Jan A; Doan V; Tverdek F; Tayar J; Ariza-Heredia E; Chemaly RF
Antiviral Res; 2016 Nov; 135():91-96. PubMed ID: 27594527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
